Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Multi-centered, randomized, open label clinical trial to study the safety and effectivity of
hydroxychloroquine + azithromycin to treat COVID-19 symptoms in primary care patients.
Phase:
Phase 2
Details
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba